SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001520138-24-000169
Filing Date
2024-04-12
Accepted
2024-04-12 15:03:04
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-KT esgh-20231231_10k.htm   iXBRL 10-KT 799270
7 GRAPHIC image_001.jpg GRAPHIC 39526
8 GRAPHIC image_002.jpg GRAPHIC 103201
  Complete submission text file 0001520138-24-000169.txt   4813059

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE esgh-20231231.xsd EX-101.SCH 39829
3 XBRL CALCULATION FILE esgh-20231231_cal.xml EX-101.CAL 62563
4 XBRL DEFINITION FILE esgh-20231231_def.xml EX-101.DEF 119563
5 XBRL LABEL FILE esgh-20231231_lab.xml EX-101.LAB 318459
6 XBRL PRESENTATION FILE esgh-20231231_pre.xml EX-101.PRE 265516
78 EXTRACTED XBRL INSTANCE DOCUMENT esgh-20231231_10k_htm.xml XML 455398
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

IRS No.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 000-56532 | Film No.: 24841131
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)